Critical roles of cold shock domain protein a as an endogenous angiogenesis inhibitor in skeletal muscle

Antioxidants and Redox Signaling

Volumn 15, Issue 8, 2011, Pages 2109-2120

  Saito, Yukihiro ^a   Nakagami, Hironori ^b   Azuma, Nobuyoshi ^a   Hirata, Satoshi ^a   Sanada, Fumihiro ^c   Taniyama, Yoshiaki ^c   Morishita, Ryuichi ^c   Kaneda, Yasufumi ^c   Sasajima, Tadahiro ^a  

^a ASAHIKAWA MEDICAL COLLEGE   (Japan)

^b OSAKA UNIVERSITY   (Japan)

^c OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS INHIBITOR; COLD SHOCK PROTEIN; CXCL2 CHEMOKINE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; I KAPPA B KINASE BETA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; INTERLEUKIN 8; PROTEIN A; REPRESSOR PROTEIN; SHORT HAIRPIN RNA; VASCULOTROPIN A;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIANGIOGENIC ACTIVITY; APOPTOSIS; ARTICLE; CELL HYPOXIA; CONTROLLED STUDY; HINDLIMB; HUMAN; HUMAN CELL; HYPOXIA; LEG ISCHEMIA; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN TARGETING; RNA TRANSPORT; SKELETAL MUSCLE;

ANGIOGENESIS INHIBITORS; ANIMALS; APOPTOSIS; BLOTTING, WESTERN; CCAAT-ENHANCER-BINDING PROTEINS; CELLS, CULTURED; CHEMOKINE CXCL2; ELECTROPHORETIC MOBILITY SHIFT ASSAY; FLUORESCENT ANTIBODY TECHNIQUE; HEAT-SHOCK PROTEINS; HINDLIMB; HUMANS; IMMUNOENZYME TECHNIQUES; INTERLEUKIN-6; INTERLEUKIN-8; ISCHEMIA; MALE; MICE; MICE, INBRED C57BL; MUSCLE, SKELETAL; NECROSIS; REAL-TIME POLYMERASE CHAIN REACTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 80052564126     PISSN: 15230864     EISSN: 15577716     Source Type: Journal    
DOI: 10.1089/ars.2010.3714     Document Type: Article

References (31)

1. Arany Z, Foo SY, Ma Y, Ruas JL, Bommi-Reddy A, Girnun G, Cooper M, Laznik D, Chinsomboon J, Rangwala SM, Baek KH, Rosenzweig A, and Spiegelman BM. HIFindependent regulation of VEGF and angiogenesis by the transcriptional coactivator PGC-1alpha. Nature 451: 1008-1012, 2008. (Pubitemid 351301733)
2. Cao R, Brakenhielm E, Pawliuk R, Wariaro D, Post MJ, Wahlberg E, Leboulch P, and Cao Y. Angiogenic synergism, vascular stability and improvement of hind-limb ischemia by a combination of PDGF-BB and FGF-2. Nat Med 9: 604-613, 2003. (Pubitemid 36597108)
3. Coles LS, Diamond P, Lambrusco L, Hunter J, Burrows J, Vadas MA, and Goodall GJ. A novel mechanism of repression of the vascular endothelial growth factor promoter, by single strand DNA binding cold shock domain (Y-box) proteins in normoxic fibroblasts. Nucleic Acids Res 30: 4845-4854, 2002. (Pubitemid 35414644)
4. Coles LS, Diamond P, Occhiodoro F, Vadas MA, and Shannon MF. Cold shock domain proteins repress transcription from the GM-CSF promoter. Nucleic Acids Res 24: 2311-2317, 1996. (Pubitemid 26194040)
5. De Martin R, Hoeth M, Hofer-Warbinek R, and Schmid JA. The transcription factor NF-kappa B and the regulation of vascular cell function. Arterioscler Thromb Vasc Biol 20: E83-E88, 2000.
6. Eklund L and Olsen BR. Tie receptors and their angiopoietin ligands are context-dependent regulators of vascular remodeling. Exp Cell Res 312: 630-641, 2006. (Pubitemid 43290339)
7. Ferrara N. Vascular endothelial growth factor: basic science and clinical progress. Endocr Rev 25: 581-611, 2004. (Pubitemid 39099316)
8. Ferrara N and Alitalo K. Clinical applications of angiogenic growth factors and their inhibitors. Nat Med 5: 1359-1364, 1999.
9. Hennebry A, Berry C, Siriett V, O'Callaghan P, Chau L, Watson T, Sharma M, and Kambadur R. Myostatin regulates fiber-type composition of skeletal muscle by regulating MEF2 and MyoD gene expression. Am J Physiol Cell Physiol 296: C525-C534, 2009.
10. Jung YJ, Isaacs JS, Lee S, Trepel J, and Neckers L. IL-1betamediated up-regulation of HIF-1alpha via an NFkappaB/COX-2 pathway identifies HIF-1 as a critical link between inflammation and oncogenesis. FASEB J 17: 2115-2117, 2003.
11. Karst AM, Gao K, Nelson CC, and Li G. Nuclear factor kappa B subunit p50 promotes melanoma angiogenesis by upregulating interleukin-6 expression. Int J Cancer 124: 494-501, 2009.
12. Kudo S, Mattei MG, and Fukuda M. Characterization of the gene for dbpA, a family member of the nucleic-acid-binding proteins containing a cold-shock domain. Eur J Biochem 231: 72-82, 1995.
13. Martin D, Galisteo R, and Gutkind JS. CXCL8/IL8 stimulates vascular endothelial growth factor (VEGF) expression and the autocrine activation of VEGFR2 in endothelial cells by activating NFkappaB through the CBM (Carma3/Bcl10/Malt1) complex. J Biol Chem 284: 6038-6042, 2009.
14. Matsumoto K and Wolffe AP. Gene regulation by Y-box proteins: coupling control of transcription and translation. Trends Cell Biol 8: 318-323, 1998. (Pubitemid 28362589)
15. Minty A and Kedes L. Upstream regions of the human cardiac actin gene that modulate its transcription in muscle cells: presence of an evolutionarily conserved repeated motif. Mol Cell Biol 6: 2125-2136, 1986.
16. Moynagh PN. The NF-kappaB pathway. J Cell Sci 118: 4589-4592, 2005.
17. Nakagami H, Morishita R, Yamamoto K, Taniyama Y, Aoki M, Yamasaki K, Matsumoto K, Nakamura T, Kaneda Y, and Ogihara T. Hepatocyte growth factor prevents endothelial cell death through inhibition of bax translocation from cytosol to mitochondrial membrane. Diabetes 51: 2604-2611, 2002. (Pubitemid 34827413)
18. Remels AH, Langen RC, Gosker HR, Russell AP, Spaapen F, Voncken JW, Schrauwen P, and Schols AM. PPARgamma inhibits NF-kappaB-dependent transcriptional activation in skeletal muscle. Am J Physiol Endocrinol Metab 297: E174-E183, 2009.
19. Rius J, Guma M, Schachtrup C, Akassoglou K, Zinkernagel AS, Nizet V, Johnson RS, Haddad GG, and Karin M. NFkappaB links innate immunity to the hypoxic response through transcriptional regulation of HIF-1alpha. Nature 453: 807-811, 2008. (Pubitemid 351793778)
20. Saito Y, Nakagami H, Kurooka M, Takami Y, Kikuchi Y, Hayashi H, Nishikawa T, Tamai K, Morishita R, Azuma N, Sasajima T, and Kaneda Y. Cold shock domain protein A represses angiogenesis and lymphangiogenesis via inhibition of serum response element. Oncogene 27: 1821-1833, 2008. (Pubitemid 351430818)
21. Saito Y, Nakagami H, Morishita R, Takami Y, Kikuchi Y, Hayashi H, Nishikawa T, Tamai K, Azuma N, Sasajima T, and Kaneda Y. Transfection of human hepatocyte growth factor gene ameliorates secondary lymphedema via promotion of lymphangiogenesis. Circulation 114: 1177-1184, 2006. (Pubitemid 44386482)
22. Sakura H, Maekawa T, Imamoto F, Yasuda K, and Ishii S. Two human genes isolated by a novel method encode DNAbinding proteins containing a common region of homology. Gene 73: 499-507, 1988. (Pubitemid 19043281)
23. Sartorelli V, Webster KA, and Kedes L. Muscle-specific expression of the cardiac alpha-actin gene requires MyoD1, CArG-box binding factor, and Sp1. Genes Dev 4: 1811-1822, 1990.
24. Sata M, Nishimatsu H, Suzuki E, Sugiura S, Yoshizumi M, Ouchi Y, Hirata Y, and Nagai R. Endothelial nitric oxide synthase is essential for the HMG-CoA reductase inhibitor cerivastatin to promote collateral growth in response to ischemia. FASEB J 15: 2530-2532, 2001.
25. Sato Y and Sonoda H. The vasohibin family: a negative regulatory system of angiogenesis genetically programmed in endothelial cells. Arterioscler Thromb Vasc Biol 27: 37-41, 2007. (Pubitemid 46360378)
26. Shannon MF, Coles LS, Vadas MA, and Cockerill PN. Signals for activation of the GM-CSF promoter and enhancer in T cells. Crit Rev Immunol 17: 301-323, 1997. (Pubitemid 27268459)
27. Shimamura M, Sato N, Taniyama Y, Yamamoto S, Endoh M, Kurinami H, Aoki M, Ogihara T, Kaneda Y, and Morishita R. Development of efficient plasmid DNA transfer into adult rat central nervous system using microbubble-enhanced ultrasound. Gene Ther 11: 1532-1539, 2004. (Pubitemid 39359461)
28. Simons M. Angiogenesis: where do we stand now? Circulation 111: 1556-1566, 2005. (Pubitemid 40470653)
29. Taniyama Y, Morishita R, Aoki M, Nakagami H, Yamamoto K, Yamazaki K, Matsumoto K, Nakamura T, Kaneda Y, and Ogihara T. Therapeutic angiogenesis induced by human hepatocyte growth factor gene in rat and rabbit hindlimb ischemia models: preclinical study for treatment of peripheral arterial disease. Gene Ther 8: 181-189, 2001. (Pubitemid 32186129)
30. Tateno K, Minamino T, Toko H, Akazawa H, Shimizu N, Takeda S, Kunieda T, Miyauchi H, Oyama T, Matsuura K, Nishi J, Kobayashi Y, Nagai T, Kuwabara Y, Iwakura Y, Nomura F, Saito Y, and Komuro I. Critical roles of musclesecreted angiogenic factors in therapeutic neovascularization. Circ Res 98: 1194-1202, 2006. (Pubitemid 43948106)
31. Wolffe AP. Structural and functional properties of the evolutionarily ancient Y-box family of nucleic acid binding proteins. Bioessays 16: 245-251, 1994. (Pubitemid 2073505)